Drug Discovery Approaches to Target E3 Ligases

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Drug Discovery

Background:

• Targeting E3 ubiquitin ligases presents a significant challenge in drug discovery, with limited ligands available despite over 600 encoded human E3 ligases.
• Few E3 ligases have been successfully modulated for targeted protein degradation (TPD) strategies due to the scarcity of small-molecule ligands.

Purpose of the Study:

• To review current academic and industrial strategies for discovering novel small-molecule ligands for E3 ligases.
• To explore the potential of these ligands in expanding druggable targets and enhancing specificity in protein degradation therapies.

Main Methods:

• Literature review of strategies employed in academia and industry for E3 ligase ligand discovery.
• Analysis of illustrative case studies showcasing successful identification of E3 ligase binders.

Main Results:

• Identification of diverse approaches for discovering E3 ligase ligands.
• Demonstration of the synergy between academic research and industrial development in this field.

Conclusions:

• The development of new E3 ligase ligands is essential for advancing targeted protein degradation.
• Collaboration between academia and industry is vital for translating fundamental research into novel therapeutics.